Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Rebastinib (DCC-2036) CAS:1020172-07-9
Rebastinib (DCC-2036)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-2196 | 100mg | 425.00 | + Add to cart |
|
| R-C-2196 | 200mg | 625.00 | + Add to cart |
|
| R-C-2196 | 500mg | 1150.00 | + Add to cart |
|
|
|
||||
Product description
Rebastinib(DCC-2036,)is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity.Multitargeted tyrosine kinase inhibitor DCC-2036 binds to and inhibits the Bcr-Abl fusion oncoprotein by changing the conformation of the folded protein to disallow ligand-dependent and ligand-independent activation;in addition,this agent binds to and inhibits Src family kinases LYN,HCK and FGR and the receptor tyrosine kinases TIE-2 and VEGFR-2.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 2 years |
Document
msds---Rebastinib (DCC-2036) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
